Synektik Spólka Akcyjna (SNT.WA)
PLN 184.4
(-1.91%)
PLN 184.4
(-1.91%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 84.63 Million PLN | 61.36% |
| 2023 | 52.45 Million PLN | 409.18% |
| 2022 | 10.3 Million PLN | 22.87% |
| 2021 | 8.38 Million PLN | -4.84% |
| 2020 | 8.81 Million PLN | -3.57% |
| 2019 | 9.13 Million PLN | -11.24% |
| 2018 | 10.29 Million PLN | 151.97% |
| 2017 | 4.08 Million PLN | 952.62% |
| 2016 | 388.09 Thousand PLN | 130.67% |
| 2015 | -1.26 Million PLN | -135.1% |
| 2014 | 3.6 Million PLN | -56.28% |
| 2013 | 8.24 Million PLN | 1378.3% |
| 2012 | -644.94 Thousand PLN | 54.61% |
| 2011 | -1.42 Million PLN | -233.57% |
| 2010 | 1.06 Million PLN | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 34.66 Million PLN | 119.09% |
| 2024 Q3 | 16.74 Million PLN | 36.87% |
| 2024 Q2 | 12.23 Million PLN | -64.71% |
| 2023 Q2 | 4.02 Million PLN | -78.89% |
| 2023 Q4 | 15.82 Million PLN | 17.08% |
| 2023 FY | 52.45 Million PLN | 409.18% |
| 2023 Q3 | 13.51 Million PLN | 235.47% |
| 2023 Q1 | 19.08 Million PLN | 747.24% |
| 2022 Q2 | 5.92 Million PLN | 232.79% |
| 2022 Q4 | 2.25 Million PLN | 548.65% |
| 2022 FY | 10.3 Million PLN | 22.87% |
| 2022 Q1 | 1.77 Million PLN | -43.87% |
| 2022 Q3 | 347.26 Thousand PLN | -94.14% |
| 2021 Q3 | -364.82 Thousand PLN | -118.31% |
| 2021 Q2 | 1.99 Million PLN | -44.44% |
| 2021 Q1 | 3.58 Million PLN | 25.59% |
| 2021 FY | 8.38 Million PLN | -4.84% |
| 2021 Q4 | 3.17 Million PLN | 968.95% |
| 2020 FY | 8.81 Million PLN | -3.57% |
| 2020 Q4 | 2.85 Million PLN | 146.13% |
| 2020 Q1 | 2.46 Million PLN | 19009.06% |
| 2020 Q2 | 2.32 Million PLN | -5.47% |
| 2020 Q3 | 1.16 Million PLN | -50.21% |
| 2019 Q1 | 8.42 Million PLN | 1018.85% |
| 2019 FY | 9.13 Million PLN | -11.24% |
| 2019 Q4 | -13.03 Thousand PLN | -115.26% |
| 2019 Q3 | 85.4 Thousand PLN | -86.6% |
| 2019 Q2 | 637.4 Thousand PLN | -92.44% |
| 2018 Q3 | 1.61 Million PLN | -78.16% |
| 2018 FY | 10.29 Million PLN | 151.97% |
| 2018 Q1 | 3.11 Million PLN | 540.45% |
| 2018 Q2 | 7.41 Million PLN | 138.13% |
| 2018 Q4 | 753.14 Thousand PLN | -53.49% |
| 2017 FY | 4.08 Million PLN | 952.62% |
| 2017 Q1 | 564.08 Thousand PLN | 42.83% |
| 2017 Q2 | 256.21 Thousand PLN | -54.58% |
| 2017 Q3 | 229.31 Thousand PLN | -10.5% |
| 2017 Q4 | 486.14 Thousand PLN | 112.0% |
| 2016 Q1 | 204.72 Thousand PLN | -91.65% |
| 2016 Q4 | 394.92 Thousand PLN | 231.28% |
| 2016 Q3 | -300.81 Thousand PLN | -11.37% |
| 2016 Q2 | -270.1 Thousand PLN | -231.93% |
| 2016 FY | 388.09 Thousand PLN | 130.67% |
| 2015 Q1 | 1.63 Million PLN | 92.58% |
| 2015 FY | -1.26 Million PLN | -135.1% |
| 2015 Q2 | -1.02 Million PLN | -162.77% |
| 2015 Q4 | 2.45 Million PLN | 184.62% |
| 2015 Q3 | -2.89 Million PLN | -182.92% |
| 2014 Q2 | 274.33 Thousand PLN | -93.89% |
| 2014 Q1 | 4.48 Million PLN | 57.02% |
| 2014 Q3 | 439.35 Thousand PLN | 60.15% |
| 2014 Q4 | 847.19 Thousand PLN | 92.83% |
| 2014 FY | 3.6 Million PLN | -56.28% |
| 2013 Q2 | 280 Thousand PLN | -90.05% |
| 2013 Q4 | 2.85 Million PLN | 371.52% |
| 2013 FY | 8.24 Million PLN | 1378.3% |
| 2013 Q3 | 606.31 Thousand PLN | 116.54% |
| 2013 Q1 | 2.81 Million PLN | 535.8% |
| 2012 Q3 | -869.32 Thousand PLN | 55.29% |
| 2012 Q4 | -645.83 Thousand PLN | 25.71% |
| 2012 Q2 | -1.94 Million PLN | 0.0% |
| 2012 FY | -644.94 Thousand PLN | 54.61% |
| 2011 FY | -1.42 Million PLN | -233.57% |
| 2010 FY | 1.06 Million PLN | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Adiuvo Investments S.A. | -10.84 Million PLN | 880.777% |
| Genomtec S.A. | -9.01 Million PLN | 1039.046% |
| Medinice S.A. | -5.07 Million PLN | 1768.695% |
| Medicalgorithmics S.A. | -578 Thousand PLN | 14742.945% |